Javlor (Vinflunine Vials) 25mg/ml x 10ml

Javlor (vinflunine) is a chemotherapy medication used for treating certain types of cancer. Administered via injection, it targets cancer cells to slow their growth. This 25mg/ml x 10ml vial pack is designed for clinical use under medical supervision.

Strength

25mg/ml x 10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Pierre Fabre

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vinflunine, the active ingredient in Javlor, is primarily used to treat advanced or metastatic urothelial carcinoma, a type of bladder cancer. It may also be prescribed for other cancers when recommended by a healthcare provider. This medication works by interfering with cancer cell division, helping to control disease progression.

Side Effects

Javlor is designed to target rapidly dividing cells, which includes cancer cells. Patients may experience effects such as fatigue, nausea, or changes in blood cell counts during treatment. These responses vary widely and should be monitored by a healthcare professional.

Precautions & Warnings

Javlor should only be handled and administered by trained medical personnel. It requires careful storage at 2–8°C to maintain stability. Patients should report any unusual symptoms, such as fever or severe fatigue, to their doctor promptly. Avoid exposure to extreme temperatures.

Avoid Interactions

Javlor may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Alcohol and certain supplements may also alter its effects. Always inform your healthcare provider about all medications and supplements you are taking before starting treatment.

Frequently Asked Questions

Javlor is used to treat advanced urothelial carcinoma, a type of bladder cancer, when other treatments are not suitable.

Javlor is given as an intravenous injection by a healthcare professional in a clinical setting.

Common effects may include fatigue, nausea, or changes in blood cell counts, which should be monitored by a doctor.

No, Javlor should be stored at 2–8°C to maintain its stability and effectiveness.

Yes, Javlor may interact with CYP3A4 inhibitors or inducers, so always inform your doctor about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.